Brief: Resverlogix strengthens board, appoints new chairman
04/04/2016 14:25
April 4 (Reuters) - Resverlogix Corp RVX.TO
* Resverlogix further strengthens the board of directors and
appoints a new chairman
* Says Norma Biln , CEO of Augurex, and Shawn Lu , CFO of
Hepalink usa inc have been appointed to Resverlogix's board
* Says Peter Johann, Resverlogix's current chairman, has
decided to step down from board of directors
Source text for Eikon: ID:nPn6ZqvfVa
Further company coverage: RVX.TO
Recent news on Resverlogix
See all newsBrief: Resverlogix Confirms Focus On Treatment Of Post Covid-19 Conditions
Brief: Resverlogix Announces New Research Findings Highlighting Safety Of BD2-Selective BET Inhibitors
Brief: Resverlogix Announces Type C Meeting With FDA For Coral, A Phase 3 High-Risk Covid-19 Outpatient Study
Brief: Resverlogix Expands Phase 2B Clinical Trial For Covid-19 Treatment With First Site In Brazil And Second In Canada
Brief: Resverlogix Announces Commencement Of Patient Enrollment And Dosing In A Phase 2B Trial For COVID-19 Treatment